Security key
78397T202
SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (SABS)
CUSIP: 78397T202
Q4 2023 13F Holders as of 31 Dec 2023
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 8,791,109
- Total 13F value
- $6,055,351
- Share change
- +8,791,109
- SEC-reported price per share
- $0.69
- Number of holders
- 3
- Value change
- +$6,055,351
- Number of buys
- 3
- Shares outstanding
- 76,568,369
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2023
Institutions
3
Top holders
3
SABS full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
SAB Biotherapeutics, Inc. SEC filings
SAB Biotherapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78397T202
Recent filing periods:
Ownership snapshot
Top reported holders of SABS - SAB Biotherapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Edward D. Hamilton
Disclosed value leader
Edward D. Hamilton
Comparable rows
0/15
Latest evidence
30 Sep 2023
3/4/5
13F
Highest disclosed value: $9,348,396
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Edward D. Hamilton has the largest disclosed position value at $9.35M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Edward D. Hamilton's linked filing trail.
Disclosed position value
Top 5
Edward D. Hamilton
$9.35M
Ilan Katz
$2.68M
VANGUARD GROUP INC
$615.5K
First PREMIER Bank
$509K
PATHSTONE FAMILY OFFICE, LLC
$319.1K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Edward D. Hamilton |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$9,348,396
9,456,382 shares
mixed-class rows
|
— | 22 Oct 2021 |
| Ilan Katz |
3/4/5
Director, 10%+ Owner
|
—
class O/S missing
|
$2,683,406
3,049,325 shares
|
— | 13 Oct 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$615,471
976,938 shares
|
— | 30 Sep 2023 |
| First PREMIER Bank |
13F
Company
|
—
class O/S missing
|
$509,000
807,535 shares
|
— | 30 Sep 2023 |
| PATHSTONE FAMILY OFFICE, LLC |
13F
Company
|
—
class O/S missing
|
$319,103
506,513 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$224,581
356,364 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
3
Shares
8,791,109
Rows available
3
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q4 2025 Across Filers
Q4 2025 holders
48
Q4 2023 holders
3
Holder diff
-45
| Investor | Q4 2025 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q4 2025 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend